Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Comparison of Sublingual Misoprostol and Intravenous Oxytocin in the Management of Postpartum Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial

Nahid Rahbar 1 , Neda Mirjan 2 and Raheb Ghorbani 3 , *
Authors Information
1 MD, Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, IR Iran
2 MD, Amir al-Momenin Hospital, Semnan University of Medical Sciences, Semnan, IR Iran
3 PhD, Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, IR Iran
Article information
  • Middle East Journal of Rehabilitation and Health: January 2018, 5 (1); e62025
  • Published Online: January 31, 2018
  • Article Type: Research Article
  • Received: October 3, 2017
  • Revised: December 30, 2017
  • Accepted: January 3, 2018
  • DOI: 10.5812/mejrh.62025

To Cite: Rahbar N, Mirjan N, Ghorbani R. Comparison of Sublingual Misoprostol and Intravenous Oxytocin in the Management of Postpartum Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial, Middle East J Rehabil Health Stud. 2018 ; 5(1):e62025. doi: 10.5812/mejrh.62025.

Abstract
Copyright © 2018, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams obstetrics, 24e. Mcgraw-hill; 2014.
  • 2. Ronsmans C, Graham WJ, Lancet Maternal Survival Series steering G. Maternal mortality: who, when, where, and why. Lancet. 2006;368(9542):1189-200. doi: 10.1016/S0140-6736(06)69380-X. [PubMed: 17011946].
  • 3. Sood AK, Singh S. Sublingual misoprostol to reduce blood loss at cesarean delivery. J Obstet Gynaecol India. 2012;62(2):162-7. doi: 10.1007/s13224-012-0168-2. [PubMed: 23543254].
  • 4. Chaudhuri P, Banerjee GB, Mandal A. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss. Int J Gynaecol Obstet. 2010;109(1):25-9. doi: 10.1016/j.ijgo.2009.11.009. [PubMed: 20070961].
  • 5. Ng PS, Chan AS, Sin WK, Tang LC, Cheung KB, Yuen PM. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour. Hum Reprod. 2001;16(1):31-5. [PubMed: 11139532].
  • 6. Mahajan NN, Mahajan K, Soni R. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor. Gynecol Obstet Invest. 2007;64(2):82. author reply 83. doi: 10.1159/000099651. [PubMed: 17308389].
  • 7. Oboro VO, Tabowei TO. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour. J Obstet Gynaecol. 2003;23(1):13-6. [PubMed: 12623474].
  • 8. Singh G, Radhakrishnan G, Guleria K. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor. Int J Gynaecol Obstet. 2009;107(2):130-4. doi: 10.1016/j.ijgo.2009.06.007. [PubMed: 19628206].
  • 9. Beigi A, Tabarestani H, Moini A, Zarrinkoub F, Kazempour M, Amree AH. Sublingual misoprostol versus intravenous oxytocin in the management of postpartum hemorrhage. Tehran Univ Med J. 2009;67(8):556-61.
  • 10. Bamigboye AA, Merrell DA, Hofmeyr GJ, Mitchell R. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand. 1998;77(2):178-81. [PubMed: 9512323].
  • 11. Harriott J, Christie L, Wynter S, DaCosta V, Fletcher H, Reid M. A randomized comparison of rectal misoprostol with syntometrine on blood loss in the third stage of labour. West Indian Med J. 2009;58(3):201-6. [PubMed: 20043525].
  • 12. Lam H, Tang OS, Lee CP, Ho PC. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstet Gynecol Scand. 2004;83(7):647-50. doi: 10.1111/j.0001-6349.2004.00572.x. [PubMed: 15225189].
  • 13. Walley RL, Wilson JB, Crane JM, Matthews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG. 2000;107(9):1111-5. [PubMed: 11002954].
  • 14. Hassan Z, Gupta S. A Randomized Comparison of Rectal Misoprostol and Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage. Nepal J Obstetr Gynaecol. 2010;4(2):44-8.
  • 15. Hofmeyr GJ, Gulmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ. 2009;87(9):666-77. [PubMed: 19784446].
  • 16. Shrestha A, Dongol A, Chawla CD, Adhikari R. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage. Kathmandu Univ Med J. 2012;9(1):8-12.
  • 17. Dabbaghi Gale T, Elmizadeh KH, Moradi SD, Rashvand Melli E. Comparison of intravenous oxytocin and oral misoprostol in reduction of postpartum hemorrhage. ZUMS J. 2012;20(81):1-8.
  • 18. Samimi M, Abedzadeh Kalahroudi M, Imani A. Comparison of the effect of rectal Misoprostol and IM Syntometrin in the prevention of post partum hemorrhage. Sci J Hamadan Univ Med Sci. 2011;18(2):38-44.
  • 19. Soleimani Z, Aghazadeh Naini A. The effectiveness of sublingual misoprostol in prevention of bleeding during cesarean delivery. Iran J Obstetr Gynecol Infertil. 2014;17(125):1-7.
  • 20. Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet. 2006;92(2):106-10. doi: 10.1016/j.ijgo.2005.10.008. [PubMed: 16343498].
  • 21. Lapaire O, Schneider MC, Stotz M, Surbek DV, Holzgreve W, Hoesli IM. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery. Int J Gynaecol Obstet. 2006;95(1):2-7. doi: 10.1016/j.ijgo.2006.05.031. [PubMed: 16934269].
  • 22. Parsons SM, Walley RL, Crane JM, Matthews K, Hutchens D. Rectal misoprostol versus oxytocin in the management of the third stage of labour. J Obstet Gynaecol Can. 2007;29(9):711-8. [PubMed: 17825135].
  • 23. Karkanis SG, Caloia D, Salenieks ME, Kingdom J, Walker M, Meffe F, et al. Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynaecol Can. 2002;24(2):149-54. [PubMed: 12196880].
  • 24. Hamm J, Russell Z, Botha T, Carlan SJ, Richichi K. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study. Am J Obstet Gynecol. 2005;192(5):1404-6. doi: 10.1016/j.ajog.2004.12.033. [PubMed: 15902121].
  • 25. Khan R. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstetr Gynecol. 2003;101(5):968-74. doi: 10.1016/s0029-7844(03)00174-1.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments